← Back to Search
Self-assembled Micelles Of Novel Amphiphilic Copolymer Cholesterol-coupled F68 Containing Cabazitaxel As A Drug Delivery System
Yanzhi Song, Qingjing Tian, Zhenjun Huang, D. Fan, Zhennan She, Xinrong Liu, Xiaobo Cheng, B. Yu, Yihui Deng
Published 2014 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Despite being one of the most promising amphiphilic block copolymers, use of Pluronic F68 in drug delivery is limited due to its high critical micelle concentration (CMC). In this study, we developed a novel F68 derivative, cholesterol-coupled F68 (F68-CHMC). This new derivative has a CMC of 10 μg/mL, which is 400-fold lower than that of F68. The drug-loading capacity of F68-CHMC was investigated by encapsulating cabazitaxel, a novel antitumor drug. Drug-loaded micelles were fabricated by a self-assembly method with simple dilution. The optimum particle size of the micelles was 17.5±2.1 nm, with an entrapment efficiency of 98.1% and a drug loading efficiency of 3.16%. In vitro release studies demonstrated that cabazitaxel-loaded F68-CHMC micelles had delayed and sustained-release properties. A cytotoxicity assay of S180 cells showed that blank F68-CHMC was noncytotoxic with a cell viability of nearly 100%, even at a concentration of 1,000 μg/mL. The IC50 revealed that cabazitaxel-loaded F68-CHMC micelles were more cytotoxic than Tween 80-based cabazitaxel solution and free cabazitaxel. In vivo antitumor activity against S180 cells also indicated better tumor inhibition by the micelles (79.2%) than by Tween 80 solution (56.2%, P<0.05). Based on these results, we conclude that the F68-CHMC copolymer may be a potential nanocarrier to improve the solubility and biological activity of cabazitaxel and other hydrophobic drugs.
This paper references
Development of amphiphilic diblock copolymers as micellar carriers of taxol
X. Zhang (1996)
Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation
Liangcen Chen (2013)
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
C. Paller (2011)
Cholesterol content in tumor tissues is inversely associated with high‐density lipoprotein cholesterol in serum in patients with gastrointestinal cancer
S. Dessi (1994)
SP1049C as first-line therapy in advanced (inoperable or metastatic) adenocarcinoma of the oesophagus: A phase II window study.
A. Armstrong (2006)
Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.
T. Whiteside (2006)
科技期刊稿件处理的精细化管理——《International Journal of Nanomedicine〉〉投稿体会
Development of Polysorbate 80/Phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models
H. Song (2011)
Cholesterol and prostate cancer
M. Freeman (2004)
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
J. Valle (2010)
Preparation and characterization of thermosensitive pluronic F127-b-poly(ɛ-caprolactone) mixed micelles.
Q. Zhou (2011)
Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers.
K. Oh (2004)
Targeting of drugs and nanoparticles to tumors
E. Ruoslahti (2010)
Synergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micelles.
Ashlynn L. Z. Lee (2011)
Effect of porous silica on sustained release behaviors of pH sensitive pluronic F127/poly(acrylic acid) hydrogels containing tulobuterol.
K. Kim (2010)
Fluorescence Probes for Critical Micelle Concentration
K. Ananthapadmanabhan (2001)
Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
Z. Wei (2009)
Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery.
A. Kabanov (2002)
Encapsulation of Curcumin in Pluronic Block Copolymer Micelles for Drug Delivery Applications
A. Sahu (2011)
Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80.
S. Simões (2005)
A multicenter phase II study of XRP6258 administered as a 1-h iv infusion every 3 weeks in taxaneresistant metastatic breast cancer patients
X Pivot (2008)
Ligands located within a cholesterol domain enhance gene delivery to the target tissue.
L. Xu (2012)
Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans.
J. M. Grindel (2002)
The use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugs.
Ashlynn L. Z. Lee (2012)
TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer.
S. Oudard (2011)
Contributions of human tumor xenografts to anticancer drug development.
E. Sausville (2006)
Novel cabazitaxel drug delivery system
Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization.
L. Zhao (2012)
Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound.
Z. Gao (2005)
Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
A. Mita (2009)
Amphiphilic block copolymers for drug delivery.
M. Adams (2003)
Effect of Doxorubicin/Pluronic SP1049C on Tumorigenicity, Aggressiveness, DNA Methylation and Stem Cell Markers in Murine Leukemia
Daria Y. Alakhova (2013)
Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization.
V. Sant (2004)
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients.
X. Pivot (2008)
Plasma lipids, lipoproteins, and familial breast cancer.
N. Boyd (1995)
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
H. Maeda (2009)
Synthesis and characterization of novel thermo-responsive F68 block copolymers with cell-adhesive RGD peptide.
Myoung-Hwa Cha (2011)
Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems.
F. Kohori (2002)
Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells.
L. Xu (2010)
Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives.
Huan Xu (2008)
Fluorescence probes for critical micelle concentration determination.
E. Goddard (1985)
In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation.
Y. Zhang (2008)
Cholesterol and breast cancer development.
C. Danilo (2012)
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
D. Liu (2011)
pH-triggered intracellular release from actively targeting polymer micelles.
X. Guo (2013)
For personal use only
This paper is referenced by
Redox-Sensitive Citronellol-Cabazitaxel Conjugate: Maintained in Vitro Cytotoxicity and Self-Assembled as Multifunctional Nanomedicine.
P. Xue (2016)
The antitumor efficacy of docetaxel is enhanced by encapsulation in novel amphiphilic polymer cholesterol-coupled tocopheryl polyethylene glycol 1000 succinate micelles
Qingjing Tian (2017)
Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630
X. Wu (2017)
Synthesis, characterization and anti-cancer activity of Pluronic F68–curcumin conjugate micelles
Yuee Cai (2016)
Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice
Saeede Enteshari (2017)
Polymeric Drug Delivery Systems Bearing Cholesterol Moieties: A Review
Paweł Misiak (2020)
Development and evaluation of polymeric micelle containing tablet formulation for poorly water-soluble drug: tamoxifen citrate
Kıvılcım Öztürk-Atar (2020)
Targeted nanoparticles from xyloglucan–doxorubicin conjugate loaded with doxorubicin against drug resistance
X. Xie (2016)
Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies
Yike Xie (2018)
Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system
W. Chen (2016)
Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity
Xiaowei Tai (2017)
Synthesis and Properties of Low-Molecular-Weight PEI-Based Lipopolymers for Delivery of DNA
Miao-Miao Xun (2018)
Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
J. Qian (2015)
Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
N. Kommineni (2019)
Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
K. Jeong (2016)
Effect of Fe 3 O 4 NPs on micellization and release behavior of CBABC-type pentablock copolymer
A. Pal (2017)
Dual Drug Loaded Biodegradable Nanofibrous Microsphere for Improving Anti-Colon Cancer Activity
Rangrang Fan (2016)
Drug Delivery Using Nanoparticles
Nicomp® DLS (2019)
Self-organized nanoparticle drug delivery systems from a folate-targeted dextran–doxorubicin conjugate loaded with doxorubicin against multidrug resistance
Yuannian Zhang (2015)
Glycyrrhetinic acid modified and pH-sensitive mixed micelles improve the anticancer effect of curcumin in hepatoma carcinoma cells
J. Song (2019)
Co-delivery of doxorubicin and itraconazole by Pluronic® P123 coated liposomes to enhance the anticancer effect in breast cancers
Yi Lin (2018)
Synthesis, characterization, and in vitro evaluation of TRAIL-modified, cabazitaxel -loaded polymeric micelles for achieving synergistic anticancer therapy
Caochuan Feng (2018)
Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects.
J. Choi (2019)
Amphiphilic copolymers modified with oleic acid and cholesterol by combining ring opening polymerization and click chemistry with improved amphotericin B loading capacity
Angie V. Angarita-Villamizar (2021)
Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation
Sadek Ahmed (2020)
Peptide functionalized poly ethylene glycol-poly caprolactone nanomicelles for specific cabazitaxel delivery to metastatic breast cancer cells.
P. Mahdaviani (2017)
Optimal synthesis of high fouling-resistant PVC-based ultrafiltration membranes with tunable surface pore size distribution and ultralow water contact angle for the treatment of oily wastewater
Tausif Ahmad (2021)
Current taxane formulations and emerging cabazitaxel delivery systems
B. Sun (2018)
A novel nanosuspension of andrographolide: Preparation, characterization and passive liver target evaluation in rats
Ligang Guo (2017)
Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer.
Bryan Hoang (2017)
Synthesis of surface-active cholesterylcontaining copolymers based on poly(maleic anhydride-co-ethyltrioxyethylene methacrylate)
Zoriana Demchuk (2015)
Polysialic acid and pluronic F127 mixed polymeric micelles of docetaxel as new approach for enhanced antitumor efficacy
T. Zhang (2017)See more